Opening a merchant account for a peptides business through 2Accept connects RUO peptide suppliers, compounding pharmacies, and physician-supervised GLP-1 platforms to acquiring banks that explicitly underwrite MCC 5912 and MCC 5122 — without the freezes, holds, and sudden terminations that aggregators like Stripe and Square issue the moment they see semaglutide, tirzepatide, BPC-157, or TB-500 in your catalog.
The process of opening a peptides merchant account with 2Accept takes four steps. First, complete the online application with your EIN, Articles of Incorporation, last three months of bank and processing statements, COAs for each product SKU, and physician oversight agreement if you sell compounded GLP-1 analogs. Second, a dedicated peptides underwriter reviews your label language, RUO disclaimers, FDA 503A/503B compliance, and chargeback ratio within one business hour. Third, you receive your MID and integrate via gateway API, hosted checkout, or Shopify after signing the merchant processing agreement. Fourth, you go live in 48 hours with chargeback alerts, fraud scoring, and multi-MID load balancing built into the account.
Rates for a peptides merchant account on 2Accept start at 3.5% for ecommerce LegitScript-certified retailers and run higher for gray-market RUO suppliers, with custom interchange-plus pricing for high-volume operators above $100K monthly. Pricing depends on monthly volume, average ticket size, chargeback ratio, whether your products are RUO or compounded prescription, and whether your account requires a domestic U.S. MID or offshore acquiring with multi-currency settlement for international fulfillment.
Every dimension below covers what peptide merchants typically evaluate when choosing a payment processor. 2Accept's peptide underwriting desk approves the products, business models, compliance configurations, and billing structures listed here without aggregator-style freezes or sudden MID terminations.
2Accept underwrites the full spectrum of peptide SKUs — from RUO research peptides sold to credentialed buyers to compounded prescription GLP-1 analogs dispensed under physician oversight. Each product category maps to a specific MCC and underwriting profile, and we structure your MID(s) so that compatible product groups share one account while incompatible groups (RUO vs. compounded Rx) get segregated MIDs.
Product positioning, label language, third-party COAs, and target buyer audience are reviewed during onboarding because they determine whether the acquirer approves the SKU under MCC 5912 (drugs / drug proprietaries), MCC 5122 (drug wholesale), or whether offshore placement is required for gray-market novel peptides.
Peptide merchants come in many shapes — pure-play RUO e-commerce, full-stack telehealth platforms with in-house prescribing and compounding pharmacy fulfillment, B2B peptide wholesale supplying research labs, and offshore gray-market suppliers serving international buyers. 2Accept underwrites all of these business configurations, matching each to the acquirer that approves the model.
Whether your business runs one-time peptide vial sales or subscription-based monthly refills, the MID is structured to support the billing cadence with tokenized vault storage and Account Updater so refill schedules don't break when customer cards expire.
Peptides sit at the intersection of FDA enforcement, card-network policy, and (for compounded Rx) state pharmacy regulation. 2Accept's underwriting desk audits your compliance posture at onboarding — RUO disclosure language, third-party COAs, FDA 503A/503B registration if applicable, LegitScript certification, and physician oversight agreements for compounded GLP-1 — and we monitor for compliance drift during the life of the MID to keep your account active through regulatory shifts.
Missing or weak compliance is the #1 cause of first-pass rejection on peptide applications. We catch the gaps before submission and coach merchants through remediation so the application clears underwriting on the first review cycle.
Peptide e-commerce is increasingly subscription-driven — monthly RUO refills, quarterly GLP-1 protocols, multi-month TRT-adjacent peptide stacks. 2Accept MIDs support recurring billing natively with tokenized card vaults, Account Updater for expired-card replacement, and cascading retry logic for declined refill attempts.
For prescribed peptides dispensed by telehealth-affiliated pharmacies, FSA/HSA card acceptance is available with Sig-IIAS inventory matching where the SKU qualifies. Multi-currency settlement is available on offshore MIDs for peptide brands shipping into the EU, UK, Canada, and APAC.
Most peptide e-commerce runs on Shopify (with a third-party gateway replacing Shopify Payments, which prohibits peptides) or WooCommerce. 2Accept ships native integrations for both, plus Magento 2 and BigCommerce for larger peptide brands. Custom storefronts integrate through REST API or hosted payment page.
For peptide telehealth platforms, we plug into the major EHR/practice-management systems — Elation, Akute, Nexhealth, Mend, Healthie — so prescription-linked billing flows through the same provider stack as charting and prescribing.
Peptide chargeback ratios run structurally higher than mainstream e-commerce because of the elevated dispute exposure on RUO products and the fraud-card use that targets novel peptide SKUs. 2Accept's risk stack catches disputes before they post (Ethoca + Verifi alerts), authenticates transactions to shift fraud liability to the issuer (3DS 2.0), and files compelling-evidence representments on friendly fraud at ~55%+ win rate.
For high-volume peptide merchants, multi-MID cascading distributes volume across 2–5 accounts so no single MID exceeds Visa's VDMP threshold (0.9%) or Mastercard's ECM threshold (1.5%).
Every high risk merchant account is priced by risk tier. Your vertical, volume, and chargeback ratio determine which tier underwrites you. Rates are average and may vary depending on individual circumstances and risk profile. Interchange may be passed to merchants for more challenging approvals.
Subscription · SaaS · Coaching · Digital
CBD · Peptides · Telehealth · Vape · Dating · Travel
Adult · Firearms · Crypto · Gaming
Complete the 4-minute application. No credit pull, no application fee, no long-term contract.
A 2Accept underwriter reviews your business model, volume, and documents within 1 business hour.
Sign your MPA, receive your MID, and integrate via gateway API, hosted checkout, or Shopify.
Grow with chargeback alerts, fraud scoring, and multi-MID load balancing as your volume scales.
Aggregators pool thousands of merchants under one master account. When any single MCC trips a threshold, entire verticals get frozen. A dedicated MID from 2Accept belongs to your business alone.
| Feature | 2Accept | Stripe | Square | PayPal |
|---|---|---|---|---|
| Vape / E-cig approved | ✓ | ✗ | ✗ | ✗ |
| CBD / Hemp approved | ✓ | ✗ | ✗ | ✗ |
| Dedicated MID (not aggregator) | ✓ | ✗ | ✗ | ✗ |
| Multi-MID load balancing | ✓ | ✗ | ✗ | ✗ |
| Human underwriter (not chatbot) | ✓ | ✗ | ✗ | ✗ |
| Firearms / Ammo approved | ✓ | ✗ | ✗ | ✗ |
| MATCH-list merchants considered | ✓ | ✗ | ✗ | ✗ |
Every 2Accept high risk merchant account includes the monitoring and mitigation stack required to stay under Visa's 1.0% chargeback threshold.
Ethoca and Verifi CDRN integrations catch disputes before they post, letting you refund pre-chargeback and protect your ratio.
Kount, Sift, and NoFraud rules block velocity attacks, BIN testing, and stolen-card fraud in real time at authorization.
Split volume across 2–5 MIDs via our cascading gateway to stay under per-MID caps and maintain chargeback ratios on every account.
Dynamic billing descriptors matched to your brand lower "I don't recognize this charge" disputes by 40%+.
3D Secure shifts liability to the issuer on authenticated transactions, eliminating fraud-based chargebacks on compliant checkouts.
Our dispute team files compelling evidence packages against friendly fraud and product-not-received disputes, recovering revenue within 45 days.
"After Stripe terminated us for selling CBD gummies, 2Accept had us live in 48 hours on a domestic MID. Zero freezes in 18 months."
"I tried four processors for my FFL store. 2Accept was the only one that understood MCC 5999 and got my ammo transactions approved."
"Our subscription box was flagged by Square for 'high chargeback volume.' 2Accept's Ethoca alerts dropped our ratio to 0.3% in one month."
A peptides merchant account is a specialized payment processing account that acquiring banks issue to peptide retailers, compounding pharmacies, and physician-supervised GLP-1 platforms, designed to handle the elevated chargeback exposure and FDA compliance scrutiny that aggregators like Stripe, Square, and PayPal refuse to underwrite. The account permits card-not-present sales of GLP-1 analogs (semaglutide, tirzepatide), BPC-157, GHK-Cu, TB-500, melanotan, and other research-use-only compounds, and it operates under tailored underwriting terms that include rolling reserves, RUO disclosure requirements, COA verification, and discount rates between 3.5% and 4.95%.
A peptides business gets a high risk classification because the FDA scrutinizes both unapproved peptide compounds and compounded prescription peptides under 21 CFR § 503A/503B, because the chargeback exposure on "for research use only" products is structurally higher than mainstream e-commerce, and because card networks treat MCC 5912 (drugs, drug proprietaries, druggist sundries) and MCC 5122 (drugs, drug proprietary, druggist sundries — wholesale) as restricted MCCs that require explicit acquirer approval. Acquiring banks also weigh whether your peptides are sold for genuine research use to credentialed buyers, whether you maintain physician oversight on compounded GLP-1 sales, and whether your label language complies with the FDA's evolving guidance on peptide marketing.
Opening a peptides merchant account differs from opening a standard low-risk account in three ways. First, underwriting takes 3 to 5 business days rather than instant approval, because the acquirer reviews COAs, physician supervision agreements, LegitScript certification (if applicable), label compliance, and your processing history. Second, pricing typically ranges from 3.5% to 4.95% rather than the 2.6%–2.9% flat rate aggregators offer, because the acquirer absorbs additional dispute exposure on RUO products. Third, the account issues a dedicated MID that belongs exclusively to your peptides business, so the account cannot be terminated for serving the peptides vertical the MID was approved to serve.
2Accept underwrites peptide merchant accounts for RUO peptide retailers, compounding pharmacies, telehealth GLP-1 platforms, and gray-market research chemical suppliers across the United States. Applications are reviewed by a dedicated peptides underwriter within one business hour, approved in 48 hours to 5 business days depending on compliance complexity, and integrated through gateway API, hosted checkout, or Shopify after signing the merchant processing agreement.
Acquiring banks segment peptide merchants by what they sell, who their buyer is, and what regulatory framework applies. The peptide verticals 2Accept underwrites most often are:
A dedicated peptides merchant account gives you advantages that no payment aggregator can match, because the account is underwritten by an acquiring bank that explicitly approves RUO peptide retail or compounded prescription peptides:
Qualifying for a peptides merchant account requires meeting documentation, entity, and compliance requirements that the acquiring bank reviews during underwriting. Standard qualification criteria include:
Keeping a peptides merchant account active long-term requires active risk management because the FDA's enforcement posture on peptide marketing shifts frequently, Visa's VDMP threshold (0.9%) and Mastercard's ECM threshold (1.5%) trigger fines and termination above either limit, and acquirers re-audit peptide MIDs more often than standard verticals. The strategies that protect a peptides MID are:
Underwriting review in 1 business hour. Full approval in 48.
Start Your Application →